Analysts Offer Insights on Healthcare Companies: Fusion Pharmaceuticals (FUSN) and ATI Physical Therapy (ATIP)
TipRanksMar 17, 2023 09:22 ET
Deutsche Bank Maintains Hold on ATI Physical Therapy, Lowers Price Target to $0.65
Benzinga Real-time NewsNov 16, 2022 09:44 ET
ATI Physical Therapy Nears 52-week Low After Jefferies Downgrades Rating
Seeking AlphaOct 27, 2022 11:12 ET
Benchmark Company Trims ATI Physical Therapy's Price Target to $2 From $4, Maintains Buy Rating
MT NewswiresAug 10, 2022 12:33 ET
ATI Physical Therapy Is Maintained at Buy by Benchmark
Dow JonesAug 10, 2022 10:28 ET
ATI Physical Therapy Price Target Cut to $2.00/Share From $4.00 by Benchmark
Dow JonesAug 10, 2022 10:28 ET
Benchmark Maintains Buy on ATI Physical Therapy, Lowers Price Target to $2
Benzinga Real-time NewsAug 10, 2022 10:18 ET
Analysts Offer Insights on Healthcare Companies: ChemoCentryx (CCXI) and ATI Physical Therapy (ATIP)
TipRanksAug 9, 2022 09:45 ET
No Data
No Data